Ravgen Gets $272.5 Million Verdict against Labcorp

Quest Diagnostics quickly settles similar litigation with biotech company over patented genetic tests

CEO SUMMARY: In September, a jury returned a $272.5 million verdict against Labcorp, representing royalties owed to biotech company Ravgen for infringement of its diagnostic genetic test patent. Soon after, Quest Diagnostics settled a similar lawsuit with Ravgen before its trial began. The victories against the two largest commercial labs illustrate the risks of navigating …

Ravgen Gets $272.5 Million Verdict against Labcorp Read More »

This post is only available to members.



You are reading premium content from The Dark Report, your primary resource for running an efficient and profitable laboratory.

Get Unlimited Access to The Dark Report absolutely FREE!

You have read 0 of 1 of your complimentary articles this month

Privacy Policy: We will never share your personal information.